NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OGIVRI® contains the active ingredient trastuzumab (rch) Consumer Medicine Information What is
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok